Humira Biosimilar Market, By Product (Reference-Based Biosimilars, Biosimilars with Modified Amino Acid Sequences, Interchangeable Biosimilars), By Indication (Rheumatoid arthritis, Psoriasis, Crohn\'s disease, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Humira Biosimilar Market size was valued at USD 790.1 Million in 2022, expanding at a CAGR of 20.9% from 2023 to 2030
Humira biosimilars represent biologic medications that closely resemble the reference biologic drug known as Humira (adalimumab). Adalimumab itself is a monoclonal antibody that targets tumor necrosis factor alpha (TNF-α) and is primarily utilized for the treatment of various autoimmune disorders. These conditions encompass rheumatoid arthritis, psoriasis, Crohn\'s disease, and ulcerative colitis. Biosimilars, on the other hand, are crafted to mirror the original drug in terms of safety, effectiveness, and quality. However, they are developed by distinct companies once the patent for the reference drug has reached its expiration.
Humira Biosimilar Market- Market Dynamics
- Increasing prevalence of autoimmune diseases and the rising demand for biologic treatments
The Humira biosimilar market is witnessing remarkable expansion, primarily driven by the expiration of Humira\'s patents in specific regions. This has paved the way for other pharmaceutical firms to enter the market and produce more cost-effective versions of the medication. Biosimilars present economical alternatives to the original drug, enhancing treatment accessibility for patients while simultaneously curbing healthcare costs. Moreover, the surging incidence of autoimmune diseases and the growing demand for biologic therapies have contributed to the heightened interest in Humira biosimilars.
On a global scale, research and diagnostic institutions are actively collaborating with government agencies to address the escalating prevalence of autoimmune conditions and the resultant increase in healthcare expenditure. Data from the National Institutes of Health (NIH) indicates that autoimmune disorders rank among the top ten causes of elevated mortality rates among women. Consequently, collaborative initiatives between institutions and governmental bodies are being initiated to tackle these health challenges more effectively.
Humira Biosimilar Market- Key Insights
- According to the insights shared by our research analyst, the global Humira Biosimilar market is poised to experience robust growth, with an estimated annual CAGR of approximately 20.9% during the forecast period from 2023 to 2030.
- Furthermore, when we examine the segmentation within this market, we find that Rheumatoid arthritis emerged as the leading indication type in terms of market share in 2022. Additionally, among the various product segments, Reference-Based Biosimilars held the dominant position in the market during the same year.
- It\'s noteworthy that North America played a pivotal role in driving the market\'s growth, as it emerged as the leading region for revenue generation in 2022.
Humira Biosimilar Market- Segmentation Analysis:
The Global Humira Biosimilar Market presents a diverse landscape, segmented based on Product, Indication, and Region. Within this dynamic market, three distinct product categories emerge: Reference-Based Biosimilars, Biosimilars with Modified Amino Acid Sequences, and Interchangeable Biosimilars. Remarkably, the Reference-Based Biosimilars segment asserted its dominance in 2022, occupying a prominent position in the market.
Reference-Based Biosimilars represent a significant facet of this market. They are meticulously developed through a direct comparison of their attributes and performance with the reference drug, Humira (adalimumab). These biosimilars are meticulously manufactured using similar cell lines and processes, resulting in a product that closely mirrors the characteristics of the reference drug.
Humira Biosimilar Market- Geographical Insights
From a geographical perspective, the market\'s footprint extends across various regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within each of these regions, numerous countries actively participate in the business landscape.
Humira Biosimilar Market- Competitive Landscape:
Enterprises operating in the Humira biosimilar market are implementing a range of strategies to establish a competitive advantage. These strategies encompass substantial investments in research and development, aimed at ensuring the biosimilars\' quality and effectiveness.
Additionally, companies are forging strategic partnerships and collaborations, tapping into complementary expertise to enhance their positions. Expanding into new geographic territories is another avenue for growth, allowing access to untapped markets. Furthermore, a focus on innovative pricing models and exceptional post-sales support serves as a means to entice a larger customer base and bolster market presence.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HUMIRA BIOSIMILAR MARKET KEY PLAYERS
- Amgen
- Samsung Bioepis
- Sandoz
- Mylan
- Boehringer Ingelheim
- Pfizer
- Fresenius Kabi
- Coherus BioSciences
- Merck & Co.
- Others
GLOBAL HUMIRA BIOSIMILAR MARKET, BY PRODUCT
- Reference-Based Biosimilars
- Biosimilars with Modified Amino Acid Sequences
- Interchangeable Biosimilars
GLOBAL HUMIRA BIOSIMILAR MARKET, BY INDICATION
- Rheumatoid arthritis
- Psoriasis
- Crohn\'s disease
- Others
GLOBAL HUMIRA BIOSIMILAR MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Humira Biosimilar Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Humira Biosimilar Market Snippet by Product
2.1.2. Humira Biosimilar Market Snippet by Indication
2.1.3. Humira Biosimilar Market Snippet by Country
2.1.4. Humira Biosimilar Market Snippet by Region
2.2. Competitive Insights
3. Humira Biosimilar Key Market Trends
3.1. Humira Biosimilar Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Humira Biosimilar Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Humira Biosimilar Market Opportunities
3.4. Humira Biosimilar Market Future Trends
4. Humira Biosimilar Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Humira Biosimilar Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Humira Biosimilar Market Landscape
6.1. Humira Biosimilar Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Humira Biosimilar Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
7.1.2. Reference-Based Biosimilars
7.1.3. Biosimilars with Modified Amino Acid Sequences
7.1.4. Interchangeable Biosimilars
8. Humira Biosimilar Market – By Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
8.1.2. Rheumatoid arthritis
8.1.3. Psoriasis
8.1.4. Crohn\'s disease
8.1.5. Others
9. Humira Biosimilar Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. Humira Biosimilar Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Humira Biosimilar Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Humira Biosimilar Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Humira Biosimilar Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Humira Biosimilar Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Humira Biosimilar Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Amgen
10.2.2. Samsung Bioepis
10.2.3. Sandoz (a division of Novartis)
10.2.4. Mylan (now part of Viatris)
10.2.5. Boehringer Ingelheim
10.2.6. Pfizer
10.2.7. Fresenius Kabi
10.2.8. Coherus BioSciences
10.2.9. Merck & Co.
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
